Position in MBX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$4,860,084
New position
Shares Held
88,045
first reported quarter
Ownership
0.183%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#53
of 172 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 99%
Shared 0%
None 1%
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRUDENTIAL FINANCIAL INC holds $557,787,882 across 190 Biotechnology names. MBX ranks #30 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
130,659 | $81,471,112 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
133,294 | $66,211,127 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
392,811 | $22,476,644 | |
| 4 | INCY |
Incyte Corp
|
191,312 | $21,687,128 | |
| 5 | CYTK |
Cytokinetics Inc
|
214,535 | $18,276,236 | |
| 6 | LGND |
Ligand Pharmaceuticals Inc
|
54,623 | $17,265,784 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
185,820 | $15,157,337 | |
| 8 | MRVI |
Maravai Lifesciences Holdings, Inc.
|
2,152,154 | $13,429,440 |
All Filings in MBX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,860,084 | 88,045 | Shares | Defined | 2026-08-12 | |
| No filing history on record for this holder in this stock. | ||||||